These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23716344)

  • 1. Serum fibrinogen is an independent prognostic factor in operable nonsmall cell lung cancer.
    Sheng L; Luo M; Sun X; Lin N; Mao W; Su D
    Int J Cancer; 2013 Dec; 133(11):2720-5. PubMed ID: 23716344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative plasma D-dimer levels predict survival in patients with operable non-small cell lung cancer independently of venous thromboembolism.
    Zhang PP; Sun JW; Wang XY; Liu XM; Li K
    Eur J Surg Oncol; 2013 Sep; 39(9):951-6. PubMed ID: 23810331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated platelet count is a strong predictor of poor prognosis in stage I non-small cell lung cancer patients.
    Ji Y; Sheng L; Du X; Qiu G; Su D
    Platelets; 2015; 26(2):138-42. PubMed ID: 24679181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative serum carcinoembryonic antigen levels in patients with pathologic stage IA nonsmall cell lung carcinoma: subnormal levels as an indicator of favorable prognosis.
    Sawabata N; Maeda H; Yokota S; Takeda S; Koma M; Tokunaga T; Ito M
    Cancer; 2004 Aug; 101(4):803-9. PubMed ID: 15305413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative serum carcinoembryonic antigen level is a prognostic factor in women with early non-small-cell lung cancer.
    Hsu WH; Huang CS; Hsu HS; Huang WJ; Lee HC; Huang BS; Huang MH
    Ann Thorac Surg; 2007 Feb; 83(2):419-24. PubMed ID: 17257963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic role of preoperative platelet, fibrinogen, and D-dimer levels in patients with non-small cell lung cancer: A multicenter prospective study.
    Hou C; Jiang F; Ma H; Zhu Q; Wang Z; Zhao B; Xue T; Tan S; Yang R; Qian Y; Luo X; Zhao M; Xu X; Chen L; Li J
    Thorac Cancer; 2019 Feb; 10(2):304-311. PubMed ID: 30609303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low Serum Levels of Pre-Surgical Total Cholesterol are Associated with Unfavorable Overall Survival in Patients with Operable Non-Small Cell Lung Cancer.
    Zhang G; Zhang D; Wu J; Zhang F; Zhu Z; Chen K; Zhang N; Jin J; Feng J; Lin N; Zhang Y; Yu H; Su D; Ying L
    Clin Lab; 2018 Mar; 64(3):321-327. PubMed ID: 29739117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Krebs von den Lungen-6 (KL-6) is a prognostic biomarker in patients with surgically resected nonsmall cell lung cancer.
    Tanaka S; Hattori N; Ishikawa N; Shoda H; Takano A; Nishino R; Okada M; Arihiro K; Inai K; Hamada H; Yokoyama A; Kohno N
    Int J Cancer; 2012 Jan; 130(2):377-87. PubMed ID: 21351094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imbalance between vascular endothelial growth factor and endostatin correlates with the prognosis of operable non-small cell lung cancer.
    Hu Y; Hu MM; Shi GL; Han Y; Li BL
    Eur J Surg Oncol; 2014 Sep; 40(9):1136-42. PubMed ID: 24998915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Preoperative Serum Aspartate Aminotransferase (AST) Level on the Prognosis of Patients with Non-Small Cell Lung Cancer.
    Chen SL; Xue N; Wu MT; Chen H; He X; Li JP; Liu WL; Dai SQ
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27598151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor response and survival in patients with advanced non-small-cell lung cancer: the predictive value of chemotherapy-induced changes in fibrinogen.
    Zhao J; Zhao M; Jin B; Yu P; Hu X; Teng Y; Zhang J; Luo Y; Zhang L; Zheng S; Zhou Q; Li H; Liu Y; Qu X
    BMC Cancer; 2012 Aug; 12():330. PubMed ID: 22852778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cluster analysis of p-glycoprotein, c-erb-B2 and P53 in relation to tumor histology strongly indicates prognosis in patients with operable non-small cell lung cancer.
    Bozcuk H; Gumus A; Ozbilim G; Sarper A; Kucukosmanoglu I; Ozbudak IH; Artac M; Ozdogan M; Samur M; Kaya A; Savas B
    Med Sci Monit; 2005 Jun; 11(6):HY11-20. PubMed ID: 15917726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma.
    Ardizzoni A; Cafferata MA; Paganuzzi M; Filiberti R; Marroni P; Neri M; Fontana V; Nicoló G; Perdelli L; Stampino CG; Rosso R; Puntoni R
    Cancer; 2001 Oct; 92(7):1896-904. PubMed ID: 11745263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative serum fibrinogen is an independent prognostic factor in operable esophageal cancer.
    Zhang SS; Lei YY; Cai XL; Yang H; Xia X; Luo KJ; Su CH; Zou JY; Zeng B; Hu Y; Luo HH
    Oncotarget; 2016 May; 7(18):25461-9. PubMed ID: 27009857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The C-reactive protein/albumin ratio predicts long-term outcomes of patients with operable non-small cell lung cancer.
    Zhang F; Ying L; Jin J; Chen K; Zhang N; Wu J; Zhang Y; Su D
    Oncotarget; 2017 Jan; 8(5):8835-8842. PubMed ID: 27823974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
    Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
    Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low socioeconomic status is a poor prognostic factor for survival in stage I nonsmall cell lung cancer and is independent of surgical treatment, race, and marital status.
    Ou SH; Zell JA; Ziogas A; Anton-Culver H
    Cancer; 2008 May; 112(9):2011-20. PubMed ID: 18361399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistently high serum carcinoembryonic antigen levels after surgery indicate poor prognosis in patients with stage I non-small-cell lung cancer.
    Wang CY; Huang MS; Huang MH; Lee HC; Hsu HS
    J Surg Res; 2010 Oct; 163(2):e45-50. PubMed ID: 20638687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum miR-19a expression correlates with worse prognosis of patients with non-small cell lung cancer.
    Lin Q; Chen T; Lin Q; Lin G; Lin J; Chen G; Guo L
    J Surg Oncol; 2013 Jun; 107(7):767-71. PubMed ID: 23609137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of circulating chromogranin A and soluble tumor necrosis factor receptors in advanced nonsmall cell lung cancer.
    Gregorc V; Spreafico A; Floriani I; Colombo B; Ludovini V; Pistola L; Bellezza G; Viganò MG; Villa E; Corti A
    Cancer; 2007 Aug; 110(4):845-53. PubMed ID: 17599769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.